200 related articles for article (PubMed ID: 8951349)
1. Cellular events involved in the sensitization of etoposide-resistant cells by inhibitors of calcium-calmodulin-dependent processes. Role for effects on apoptosis, DNA cleavable complex, and phosphorylation.
Kawamura K; Grabowski D; Krivacic K; Hidaka H; Ganapathi R
Biochem Pharmacol; 1996 Dec; 52(12):1903-9. PubMed ID: 8951349
[TBL] [Abstract][Full Text] [Related]
2. Tumor cell resistance to topoisomerase II poisons: role for intracellular free calcium in the sensitization by inhibitors or calcium-calmodulin-dependent enzymes.
Grabowski DR; Dubyak GR; Rybicki L; Hidaka H; Ganapathi R
Biochem Pharmacol; 1998 Aug; 56(3):345-9. PubMed ID: 9744572
[TBL] [Abstract][Full Text] [Related]
3. Cell cycle phase specificity in the potentiation of etoposide-induced DNA damage and apoptosis by KN-62, an inhibitor of calcium-calmodulin-dependent enzymes.
Aoyama M; Grabowski DR; Holmes KA; Rybicki LA; Bukowski RM; Ganapathi MK; Ganapathi R
Biochem Pharmacol; 2001 Jan; 61(1):49-54. PubMed ID: 11137708
[TBL] [Abstract][Full Text] [Related]
4. Resistance to etoposide in human leukemia HL-60 cells: reduction in drug-induced DNA cleavage associated with hypophosphorylation of topoisomerase II phosphopeptides.
Ganapathi R; Constantinou A; Kamath N; Dubyak G; Grabowski D; Krivacic K
Mol Pharmacol; 1996 Aug; 50(2):243-8. PubMed ID: 8700130
[TBL] [Abstract][Full Text] [Related]
5. The influence of hyaluronan-CD44 interaction on topoisomerase II activity and etoposide cytotoxicity in head and neck cancer.
Wang SJ; Peyrollier K; Bourguignon LY
Arch Otolaryngol Head Neck Surg; 2007 Mar; 133(3):281-8. PubMed ID: 17372087
[TBL] [Abstract][Full Text] [Related]
6. c-IAP1 is overexpressed in HL-60 cells selected for doxorubicin resistance: effects on etoposide-induced apoptosis.
Vaziri SA; Grabowski DR; Tabata M; Holmes KA; Sterk J; Takigawa N; Bukowski RM; Ganapathi MK; Ganapathi R
Anticancer Res; 2003; 23(5A):3657-61. PubMed ID: 14666661
[TBL] [Abstract][Full Text] [Related]
7. Attenuation of drug-stimulated topoisomerase II-DNA cleavable complex formation in wild-type HL-60 cells treated with an intracellular calcium buffer is correlated with decreased cytotoxicity and site-specific hypophosphorylation of topoisomerase IIalpha.
Aoyama M; Grabowski DR; Dubyak GR; Constantinou AI; Rybicki LA; Bukowski RM; Ganapathi MK; Hickson ID; Ganapathi R
Biochem J; 1998 Dec; 336 ( Pt 3)(Pt 3):727-33. PubMed ID: 9841887
[TBL] [Abstract][Full Text] [Related]
8. Expression of Ca2+/calmodulin-dependent protein kinase types II and IV, and reduced DNA synthesis due to the Ca2+/calmodulin-dependent protein kinase inhibitor KN-62 (1-[N,O-bis(5-isoquinolinesulfonyl)-N-methyl-L-tyrosyl]-4-phenyl piperazine) in small cell lung carcinoma.
Williams CL; Phelps SH; Porter RA
Biochem Pharmacol; 1996 Mar; 51(5):707-15. PubMed ID: 8615909
[TBL] [Abstract][Full Text] [Related]
9. Calmodulin inhibitor trifluoperazine in combination with doxorubicin induces the selection of tumour cells with the multidrug resistant phenotype.
Kamath N; Grabowski D; Ford J; Ganapathi R
Br J Cancer; 1993 Jun; 67(6):1203-8. PubMed ID: 8099806
[TBL] [Abstract][Full Text] [Related]
10. Topoisomerase II inhibitors fail to induce chromosome-type aberrations in etoposide-resistant cells: evidence for essential contribution of the cleavable complex formation to the induction of chromosome-type aberrations.
Suzuki H; Tarumoto Y; Ohsawa M
Mutagenesis; 1997 Jan; 12(1):29-33. PubMed ID: 9025094
[TBL] [Abstract][Full Text] [Related]
11. Trifluoperazine modulation of resistance to the topoisomerase II inhibitor etoposide in doxorubicin resistant L1210 murine leukemia cells.
Kamath N; Grabowski D; Ford J; Drake F; Kerrigan D; Pommier Y; Ganapathi R
Cancer Commun; 1991 Feb; 3(2):37-44. PubMed ID: 1995027
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of voltage-gated Ca2+ channel activity in small cell lung carcinoma by the Ca2+/calmodulin-dependent protein kinase inhibitor KN-62 (1-[N,O-bis(5-isoquinolinesulfonyl)-N-methyl-L-tyrosyl]-4-phenylpiperaz ine) .
Williams CL; Porter RA; Phelps SH
Biochem Pharmacol; 1995 Dec; 50(12):1979-85. PubMed ID: 8849323
[TBL] [Abstract][Full Text] [Related]
13. Dependence of insulin secretion from permeabilized pancreatic beta-cells on the activation of Ca(2+)/calmodulin-dependent protein kinase II. A re-evaluation of inhibitor studies.
Bhatt HS; Conner BP; Prasanna G; Yorio T; Easom RA
Biochem Pharmacol; 2000 Dec; 60(11):1655-63. PubMed ID: 11077048
[TBL] [Abstract][Full Text] [Related]
14. The involvement of calmodulin and Ca2+/calmodulin-dependent protein kinase II in the circadian rhythms controlled by the suprachiasmatic nucleus.
Fukushima T; Shimazoe T; Shibata S; Watanabe A; Ono M; Hamada T; Watanabe S
Neurosci Lett; 1997 May; 227(1):45-8. PubMed ID: 9178855
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of M3 muscarinic acetylcholine receptor-mediated Ca2+ influx and intracellular Ca2+ mobilization in neuroblastoma cells by the Ca2+/calmodulin-dependent protein kinase inhibitor 1-[N,O-bis(5-isoquinolinesulfonyl)-N-methyl-L-trosyl]-4-phenylpiperazin e (KN-62).
Puhl HL; Raman PS; Williams CL; Aronstam RS
Biochem Pharmacol; 1997 Apr; 53(8):1107-14. PubMed ID: 9175715
[TBL] [Abstract][Full Text] [Related]
16. Moxifloxacin enhances etoposide-induced cytotoxic, apoptotic and anti-topoisomerase II effects in a human colon carcinoma cell line.
Reuveni D; Halperin D; Shalit I; Priel E; Fabian I
Int J Oncol; 2010 Aug; 37(2):463-71. PubMed ID: 20596674
[TBL] [Abstract][Full Text] [Related]
17. KN-62, 1-[N,O-bis(5-isoquinolinesulfonyl)-N-methyl-L-tyrosyl]-4-phenylpiperazi ne, a specific inhibitor of Ca2+/calmodulin-dependent protein kinase II.
Tokumitsu H; Chijiwa T; Hagiwara M; Mizutani A; Terasawa M; Hidaka H
J Biol Chem; 1990 Mar; 265(8):4315-20. PubMed ID: 2155222
[TBL] [Abstract][Full Text] [Related]
18. Altered stability of etoposide-induced topoisomerase II-DNA complexes in resistant human leukaemia K562 cells.
Ritke MK; Roberts D; Allan WP; Raymond J; Bergoltz VV; Yalowich JC
Br J Cancer; 1994 Apr; 69(4):687-97. PubMed ID: 8142256
[TBL] [Abstract][Full Text] [Related]
19. 1-[N, O-bis-(5-isoquinolinesulphonyl)-N-methyl-L-tyrosyl]-4- phenylpiperazine (KN-62), an inhibitor of calcium-dependent camodulin protein kinase II, inhibits both insulin- and hypoxia-stimulated glucose transport in skeletal muscle.
Brozinick JT; Reynolds TH; Dean D; Cartee G; Cushman SW
Biochem J; 1999 May; 339 ( Pt 3)(Pt 3):533-40. PubMed ID: 10215590
[TBL] [Abstract][Full Text] [Related]
20. Transfection of a human topoisomerase II alpha gene into etoposide-resistant human breast tumor cells sensitizes the cells to etoposide.
Asano T; An T; Zwelling LA; Takano H; Fojo AT; Kleinerman ES
Oncol Res; 1996; 8(3):101-10. PubMed ID: 8823806
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
